跳至主要内容
临床试验/NCT00398229
NCT00398229已完成2 期

The Benefit of Human Chorionic Gonadotropin (hCG) Supplementation Throughout the Secretory Phase of Frozen-Thawed Embryo Transfer Cycles

Hadassah Medical Organization1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2006年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
300
试验地点
1
主要终点
implantation rate

研究概览

简要总结

The implantation rate after frozen-thawed embryo transfer cycles depends mostly on the receptivity of the endometrium and the embryo quality.The effects of human chorionic gonadotropins (hCG) on the endometrium have been investigated for several years. hCG was shown to up-regulate gene expression during the differentiation of human endometrial stromal cells into decidua. The aim of our study was to assess the benefit of hCG supplementation throughout the secretory phase of artificial frozen-thawed embryo transfer cycles.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • all women on frozen-thawed embryo-transfer cycle

排除标准

  • any allergy to injection of human chorionic gonadotropin before

研究组 & 干预措施

A

Active Comparator

receiving hCG injection

干预措施: s.c. human chorionic gonadotropin (Ovitrelle) (Drug)

B

Placebo Comparator

干预措施: s.c. human chorionic gonadotropin (Ovitrelle) (Drug)

结局指标

主要结局

implantation rate

时间窗: 4 weeks

pregnancy rate

时间窗: 4 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验